Metoprolol Improves Endothelial Function in Patients with Cardiac Syndrome X

AuthorMaryam Majidiniaen
AuthorYousef Rasmien
AuthorMohammad Hassan Khadem Ansarien
AuthorMirHossein Seyed-Mohammadzaden
AuthorEhsan Sabooryen
AuthorAlireza Shirpooren
Issued Date2016-07-31en
AbstractEndothelial dysfunction which is manifested by the loss of nitric oxide bioavailability, is an increasingly recognized cause of cardiac syndrome X (CSX) and beta blockers are used for the treatment of this syndrome. Thus, the aim of this study was to investigate effects of metoprolol, as a beta blocker, on endothelial function in CSX patients.en
DOIhttps://doi.org/10.22037/ijpr.2016.1869en
KeywordMetoprololen
KeywordEndothelial functionen
KeywordCardiac syndrome Xen
KeywordAngiographyen
KeywordNitric oxideen
PublisherBrieflandsen
TitleMetoprolol Improves Endothelial Function in Patients with Cardiac Syndrome Xen
TypeOriginal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijpr-15-561.pdf
Size:
513.58 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF